Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Oct;15(10):742-7.
doi: 10.1111/jch.12185. Epub 2013 Aug 19.

Assessment of target organ damage in the evaluation and follow-up of hypertensive patients: where do we stand?

Affiliations
Review

Assessment of target organ damage in the evaluation and follow-up of hypertensive patients: where do we stand?

Gadi Shlomai et al. J Clin Hypertens (Greenwich). 2013 Oct.

Abstract

Hypertension is associated with damage to the heart, kidneys, and vascular tree. Assessment of target organ damage (TOD) allows better prediction of cardiovascular risk than conventional risk assessment. Regression of TOD during antihypertensive treatment, which depends on the blood pressure (BP) reduction and the specific ancillary properties of each drug, may indirectly indicate that BP is well controlled. It is unclear whether regression of TOD during treatment is associated with favorable outcome and should be used as a surrogate endpoint. There is evidence that regression of left ventricular hypertrophy and albuminuria are associated with a favorable outcome. However, recent studies cast doubts on this evidence. Thus, assessment of TOD is important to define cardiovascular risk, but, so far, regression of TOD cannot be regarded as a major surrogate therapeutic target. The present paper will provide a critical overview of the data available in the literature.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Routine and recommended examinations for evaluation of target organ damage (OD) according to European Society of Hypertension/European Society of Cardiology 2007 guidelines. SCr indicates serum creatinine; CrCl, creatinine clearance; GFR, glomerular filtration rate; MA, microalbuminuria; EKG, electrocardiography; LVH, left ventricular hypertrophy; LA, left atrial; CA, carotid artery; PWV, pulse wave velocity.

Comment in

References

    1. Mancia G, Laurent S, Agabiti‐Rosei E, et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens. 2009;27:2121–2158. - PubMed
    1. Mancia G, De Backer G, Dominiczak A, et al. 2007 ESH‐ESC Practice Guidelines for the Management of Arterial Hypertension: ESH‐ESC Task Force on the Management of Arterial Hypertension. J Hypertens. 2007;25:1751–1762. - PubMed
    1. Rothwell PM, Price JF, Fowkes FG, et al. Short‐term effects of daily aspirin on cancer incidence, mortality, and non‐vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials. Lancet. 2012;379:1602–1612. - PubMed
    1. Sever PS, Dahlof B, Poulter NR, et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower‐than‐average cholesterol concentrations, in the Anglo‐Scandinavian Cardiac Outcomes Trial–Lipid Lowering Arm (ASCOT‐LLA): a multicentre randomised controlled trial. Lancet. 2003;361:1149–1158. - PubMed
    1. Patel A, MacMahon S, Chalmers J, et al. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet. 2007;370:829–840. - PubMed